TY - JOUR T1 - Neuropsychiatric and cognitive symptoms across the Alzheimer’s disease clinical spectrum: Cross-sectional and longitudinal associations JF - medRxiv DO - 10.1101/2021.02.18.21251064 SP - 2021.02.18.21251064 AU - Willem S. Eikelboom AU - Esther van den Berg AU - Ellen Singleton AU - Sara J. Baart AU - Michiel Coesmans AU - Annebet E. Leeuwis AU - Charlotte E. Teunissen AU - Bart N.M. van Berckel AU - Yolande A.L. Pijnenburg AU - Philip Scheltens AU - Wiesje M. van der Flier AU - Rik Ossenkoppele AU - Janne M. Papma Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/20/2021.02.18.21251064.abstract N2 - Objective To investigate the prevalence and trajectories of neuropsychiatric symptoms (NPS) in relation to cognitive functioning in a cohort of amyloid-β positive individuals across the Alzheimer’s disease (AD) clinical spectrum.Methods We included 1,524 amyloid-β positive individuals from the Amsterdam Dementia Cohort with subjective cognitive decline (SCD, n=113), mild cognitive impairment (MCI, n=321), or dementia (n=1,090). We measured NPS with the neuropsychiatric inventory (NPI), examining total scores and the presence of specific NPI-items. Cognition was assessed across five cognitive domains and with the MMSE. We examined trajectories including model based trends for NPS and cognitive functioning over time. We used linear mixed models to relate baseline NPI scores to cognitive functioning at baseline (whole-sample) and longitudinal time-points (subsample n=520, Mean=1.8 [SD=0.7] years follow-up).Results NPS were prevalent across all clinical AD stages (NPI total score ≥1 81.4% in SCD, 81.2% in MCI, 88.7% in dementia). Cognitive functioning showed an uniform gradual decline; while in contrast, large intra-individual heterogeneity of NPS was observed over time across all groups. At baseline, we found associations between NPS and cognition in dementia that were most pronounced for NPI total scores and MMSE (range β:-0.18–0.11, FDR-adjusted p<0.05), while there were no cross-sectional relationships in SCD and MCI (β:-0.32– 0.36, FDR-adjusted p>0.05). There were no associations between baseline NPS and cognitive functioning over time in any clinical stage (β:-0.13–0.44, FDR-adjusted p>0.05).Conclusion NPS and cognitive symptoms are both prevalent across the AD continuum, but show a different evolution during the course of the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by an Alzheimer Nederland and Memorabel ZonMw Grant 733050823 (Deltaplan Dementie) to JMP and RO. Research of the Amsterdam UMC Alzheimer Centre is part of the neurodegeneration research program of the Neuroscience Campus Amsterdam. The Amsterdam UMC Alzheimer Centre is supported by Alzheimer Nederland and Stichting VUmc Fonds. WF holds the Pasman chair.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Medical Ethics Review Committee of the Amsterdam University Medical Centers approved the study. Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not provided in the article and additional information on methods and materials can be shared upon reasonable request. ER -